Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 280

1.

Lymph Node Status After Neoadjuvant Chemoradiotherapy for Esophageal Cancer: Implications for the Extent of Lymphadenectomy.

Robb WB, Maillard E, Mariette C.

Ann Surg. 2017 Dec;266(6):e53-e54. doi: 10.1097/SLA.0000000000001403. No abstract available.

PMID:
29136963
2.

A structured training program for minimally invasive esophagectomy for esophageal cancer- a Delphi consensus study in Europe.

Visser E, van Rossum PSN, van Veer H, Al-Naimi K, Chaudry MA, Cuesta MA, Gisbertz SS, Gutschow CA, Hölscher AH, Luyer MDP, Mariette C, Moorthy K, Nieuwenhuijzen GAP, Nilsson M, Räsänen JV, Schneider PM, Schröder W, Cheong E, van Hillegersberg R.

Dis Esophagus. 2017 Nov 7. doi: 10.1093/dote/dox124. [Epub ahead of print]

PMID:
29121243
3.

Impact of RAS Mutations in Metastatic Colorectal Cancer After Potentially Curative Resection: Does Site of Metastases Matter?

Passot G, Kim BJ, Glehen O, Mehran RJ, Kopetz SE, Goere D, Overman MJ, Pocard M, Marchal F, Conrad C, Aloia TA, Vauthey JN, Chun YS; BIG-RENAPE Working Group.

Ann Surg Oncol. 2017 Oct 25. doi: 10.1245/s10434-017-6141-7. [Epub ahead of print]

PMID:
29071660
4.

Depletion of MUC5B mucin in gastrointestinal cancer cells alters their tumorigenic properties: implication of the Wnt/β-catenin pathway.

Lahdaoui F, Messager M, Vincent A, Hec F, Gandon A, Warlaumont M, Renaud F, Leteurtre E, Piessen G, Jonckheere N, Mariette C, Van Seuningen I.

Biochem J. 2017 Nov 1;474(22):3733-3746. doi: 10.1042/BCJ20170348.

PMID:
28972071
5.

Discrepancy Between Clinical and Pathologic Nodal Status of Esophageal Cancer and Impact on Prognosis and Therapeutic Strategy.

Markar SR, Gronnier C, Pasquer A, Duhamel A, Behal H, Théreaux J, Gagnière J, Lebreton G, Brigand C, Renaud F, Piessen G, Meunier B, Collet D, Mariette C; FREGAT Working Group—FRENCH—AFC.

Ann Surg Oncol. 2017 Dec;24(13):3911-3920. doi: 10.1245/s10434-017-6088-8. Epub 2017 Sep 25.

PMID:
28948524
6.

Formation of local spin-state concentration waves during the relaxation from a photoinduced state in a spin-crossover polymer.

Mariette C, Trzop E, Zerdane S, Fertey P, Zhang D, Valverde-Muñoz FJ, Real JA, Collet E.

Acta Crystallogr B Struct Sci Cryst Eng Mater. 2017 Aug 1;73(Pt 4):660-668. doi: 10.1107/S2052520617007685. Epub 2017 Jul 27.

PMID:
28762976
7.

Impact of Extracapsular Lymph Node Involvement After Neoadjuvant Chemoradiation Therapy Followed by Surgery in Carcinoma of the Esophagus: A Multicenter Study.

Depypere LP, Moons J, Mariette C, D'Journo XB, Thomas PA, Hölscher AH, Bollschweiler E, van Berge-Henegouwen MI, Van Lanschot JJB, Lerut TEMR, Nafteux PR.

Ann Surg. 2017 Jul 24. doi: 10.1097/SLA.0000000000002425. [Epub ahead of print]

PMID:
28742714
8.

Survival Benefit of Neoadjuvant Treatment in Clinical T3N0M0 Esophageal Cancer: Results From a Retrospective Multicenter European Study.

Mantziari S, Gronnier C, Renaud F, Duhamel A, Théreaux J, Brigand C, Carrère N, Lefevre JH, Pasquer A, Demartines N, Collet D, Meunier B, Mariette C; FREGAT working group – FRENCH – AFC.

Ann Surg. 2017 Nov;266(5):805-813. doi: 10.1097/SLA.0000000000002402.

PMID:
28742698
9.

Are Thoracotomy and/or Intrathoracic Anastomosis Still Predictors of Postoperative Mortality After Esophageal Cancer Surgery?: A Nationwide Study.

Degisors S, Pasquer A, Renaud F, Béhal H, Hec F, Gandon A, Vanderbeken M, Caranhac G, Duhamel A, Piessen G, Mariette C; FREGAT working group.

Ann Surg. 2017 Nov;266(5):854-862. doi: 10.1097/SLA.0000000000002401.

PMID:
28742697
10.

Neoadjuvant chemoradiotherapy for oesophageal cancer: Still looking for a challenger to the CROSS regimen.

Adenis A, Mariette C.

Eur J Cancer. 2017 Sep;83:331-332. doi: 10.1016/j.ejca.2017.06.039. Epub 2017 Jul 20. No abstract available.

PMID:
28736189
11.

Resectable invasive IPMN versus sporadic pancreatic adenocarcinoma of the head of the pancreas: Should these two different diseases receive the same treatment? A matched comparison study of the French Surgical Association (AFC).

Duconseil P, Périnel J, Autret A, Adham M, Sauvanet A, Chiche L, Mabrut JY, Tuech JJ, Mariette C, Régenet N, Fabre JM, Bachellier P, Delpéro JR, Paye F, Turrini O.

Eur J Surg Oncol. 2017 Sep;43(9):1704-1710. doi: 10.1016/j.ejso.2017.06.011. Epub 2017 Jun 29.

PMID:
28687431
12.

What is the impact of neoadjuvant chemoradiation on outcomes in gastro-intestinal cancer?

Mariette C, Brouquet A, Tzanis D, Laurenzi A, de la Rochefordière A, Mariani P, Piessen G, Sa Cunha A, Penna C.

J Visc Surg. 2017 Jun;154(3):185-195. doi: 10.1016/j.jviscsurg.2017.05.004. Epub 2017 Jun 9.

PMID:
28602545
13.

ICORG 10-14: NEOadjuvant trial in Adenocarcinoma of the oEsophagus and oesophagoGastric junction International Study (Neo-AEGIS).

Reynolds JV, Preston SR, O'Neill B, Baeksgaard L, Griffin SM, Mariette C, Cuffe S, Cunningham M, Crosby T, Parker I, Hofland K, Hanna G, Svendsen LB, Donohoe CL, Muldoon C, O'Toole D, Johnson C, Ravi N, Jones G, Corkhill AK, Illsley M, Mellor J, Lee K, Dib M, Marchesin V, Cunnane M, Scott K, Lawner P, Warren S, O'Reilly S, O'Dowd G, Leonard G, Hennessy B, Dermott RM.

BMC Cancer. 2017 Jun 3;17(1):401. doi: 10.1186/s12885-017-3386-2.

14.

Randomized clinical trial of biodegradeable intraluminal sheath to prevent anastomotic leak after stapled colorectal anastomosis.

Bakker IS, Morks AN, Ten Cate Hoedemaker HO, Burgerhof JGM, Leuvenink HG, van Praagh JB, Ploeg RJ, Havenga K; Collaborative C-seal Study Group.

Br J Surg. 2017 Jul;104(8):1010-1019. doi: 10.1002/bjs.10534. Epub 2017 May 10.

PMID:
28488729
15.

Statistical Tools for Propensity Score Matching.

Duhamel A, Labreuche J, Gronnier C, Mariette C.

Ann Surg. 2017 Jun;265(6):E79-E80. doi: 10.1097/SLA.0000000000001312. No abstract available.

PMID:
28486297
16.

Successful immunosuppressant-free heterotopic transplantation of tracheal allografts in the pig.

De Wolf J, Brieu M, Zawadzki C, Ung A, Kipnis E, Jashari R, Hubert T, Fayoux P, Mariette C, Copin MC, Wurtz A.

Eur J Cardiothorac Surg. 2017 Aug 1;52(2):248-255. doi: 10.1093/ejcts/ezx116.

PMID:
28472471
17.

Reply to Letter: "Tumor Response and Lymph Node Status After Neoadjuvant Chemoradiotherapy for Esophageal Cancer".

Robb WB, Mariette C.

Ann Surg. 2017 May;265(5):e69-e70. doi: 10.1097/SLA.0000000000001263. No abstract available.

PMID:
28394794
18.

Same-day discharge in benign esophageal surgery: a prospective cohort study.

Desbeaux A, Gronnier C, Piessen G, Vanderbeken M, Ruolt N, Triboulet JP, Mariette C.

Dis Esophagus. 2017 Apr 1;30(4):1-7. doi: 10.1093/dote/dow036.

PMID:
28375480
19.

Surgically treated oesophageal cancer developed in a radiated field: Impact on peri-operative and long-term outcomes.

Markar SR, Gronnier C, Pasquer A, Duhamel A, Behal H, Théreaux J, Gagnière J, Lebreton G, Brigand C, Meunier B, Collet D, Mariette C; FREGAT working group – FRENCH – AFC.

Eur J Cancer. 2017 Apr;75:179-189. doi: 10.1016/j.ejca.2016.12.036. Epub 2017 Feb 23.

PMID:
28236769
20.

What is the optimal neoadjuvant treatment for locally advanced oesophageal adenocarcinoma?

Mariette C.

Ann Oncol. 2017 Mar 1;28(3):447-450. doi: 10.1093/annonc/mdw644. No abstract available.

PMID:
27993810

Supplemental Content

Loading ...
Support Center